Publications

Selected Publications

2024

  1. MRR
    Advances in reversible covalent kinase inhibitors
    Zheng Zhao, and Philip E. Bourne
    Medicinal Research Reviews, 2024
    HTML
  2. JCIM
    Exploring Extended Warheads toward Developing Cysteine-Targeted Covalent Kinase Inhibitors
    Zheng Zhao, and Philip E. Bourne
    Journal of Chemical Information and Modeling, 2024
    HTML

2023

  1. JCIM
    Analysis of KRAS-Ligand Interaction Modes and Flexibilities Reveals the Binding Characteristics
    Z. Zhao, N. Bohidar, and P. E. Bourne
    J Chem Inf Model, 2023
    HTML
  2. ACS PTS
    Rigid Scaffolds Are Promising for Designing Macrocyclic Kinase Inhibitors
    Zheng Zhao, and Philip E. Bourne
    ACS Pharmacology & Translational Science, 2023
    HTML
  3. ACS MCL
    How Ligands Interact with the Kinase Hinge
    Zheng Zhao, and Philip E. Bourne
    ACS Medicinal Chemistry Letters, 2023
    HTML

2022

  1. Pharma
    Systematic Exploration of Privileged Warheads for Covalent Kinase Drug Discovery
    Z. Zhao, and P. E. Bourne
    Pharmaceuticals (Basel), 2022
    HTML
  2. DDT
    Harnessing systematic protein-ligand interaction fingerprints for drug discovery
    Z. Zhao, and P. E. Bourne
    Drug Discov Today, 2022
    HTML

2021

  1. Book Sec.
    Using the Structural Kinome to Systematize Kinase Drug Discovery
    Zheng Zhao, and Philip E. Bourne
    2021
    HTML

2020

  1. JCTC
    Revealing Acquired Resistance Mechanisms of Kinase-Targeted Drugs Using an on-the-Fly, Function-Site Interaction Fingerprint Approach
    Z. Zhao, and P. E. Bourne
    J. Chem. Theory Comput., 2020
    HTML
  2. JPR
    Structural Insights into the Binding Modes of Viral RNA-Dependent RNA Polymerases Using a Function-Site Interaction Fingerprint Method for RNA Virus Drug Discovery
    Z. Zhao, and P. E. Bourne
    J. Proteome Res., 2020
    HTML
  3. Book Sec
    Overview of Current Type I/II Kinase Inhibitors
    Zheng Zhao, and Philip E. Bourne
    2020
    HTML

2019

  1. JCIM
    Structural Insights into Characterizing Binding Sites in Epidermal Growth Factor Receptor Kinase Mutants
    Z. Zhao, L. Xie, and P. E. Bourne
    J. Chem. Inf. Model., 2019
    HTML

2018

  1. DDT
    Progress with covalent small-molecule kinase inhibitors
    Z. Zhao, and P. E. Bourne
    Drug Discov. Today, 2018
    HTML

2017

  1. PLoS One
    Insights into the binding mode of MEK type-III inhibitors. A step towards discovering and designing allosteric kinase inhibitors across the human kinome
    Z. Zhao, L. Xie, and P. E. Bourne
    PLoS One, 2017
    HTML
  2. JMC
    Determining Cysteines Available for Covalent Inhibition Across the Human Kinome
    Z. Zhao, Q. Liu, S. Bliven, and 2 more authors
    J. Med. Chem., 2017
    HTML

2016

  1. JMC
    Delineation of Polypharmacology across the Human Structural Kinome Using a Functional Site Interaction Fingerprint Approach
    Z. Zhao, L. Xie, L. Xie, and 1 more author
    J. Med. Chem., 2016
    HTML

2015

  1. ACS Cat
    Deriving Chemically Essential Interactions Based on Active Site Alignments and Quantum Chemical Calculations: A Case Study on Glycoside Hydrolases
    Yinliang Zhang, Zheng Zhao*, and Haiyan Liu*
    ACS Catalysis, 2015
    HTML

2014

  1. ACS CB
    Exploration of type II binding mode: A privileged approach for kinase inhibitor focused drug discovery?
    Z. Zhao, H. Wu, L. Wang, and 4 more authors
    ACS Chem. Biol., 2014
    HTML